Oncopharmpod
Zanubrutinib
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:20:29
- Mas informaciones
Informações:
Sinopsis
BTK-targeting therapy approved again! Zanubrutinib approved for Mantle Cell Lymphoma (2nd line) - how does it compare to ibrutinib and acalabrutinib?
